Learn more about the people and groups that further research at the Joslin Diabetes Center  |  Select an application from the list below:  |  Search JoslinResearch.org  |  Learn about JoslinResearch.org and its features  |  Contact us with questions or to let us know about problems  |  Login to use all our features
Joslin Diabetes Center Website
  Harvard Medical School
Joslin Research Home  
Harvard Medical School Joslin Research Home
Welcome to the Joslin Research Website                     
 
  Joslin Investigator:
   
  
Om P. Ganda, M.D.
 
Investigator Specifics:
Professional Details:
Publications
CV

Member of Section:
Clinical Research Section


 
 
Om P. Ganda, MD
Investigator
Joslin Diabetes Center
 
7/28/1973 -  
 
 Focus on Prevention and Treatment

A Co-Investigator in the landmark Diabetes Control and Complications Trial (DCCT), completed in 1983, Om P. Ganda, MD, has been engaged in clinical diabetes research for more than three decades. The DCCT demonstrated the importance of glucose control in preventing complications in type 1 diabetes. Dr. Ganda is now a Co-Investigator of Epidemiology of Diabetes Intervention and Complications (EDIC), an ongoing long-term follow-up study.

In addition to his clinical research and teaching, Dr. Ganda directs the Lipid Center at Joslin, where he treats patients with elevated cholesterol and triglycerides. He is also studying why patients with Type 2 diabetes have increased susceptibility to cardiovascular disease and elevated lipids. He is a Co-Investigator of several ongoing clinical trials to identify better medications for people who have difficulty with exercise and diet control. The goal is to find one pill that will control not only cholesterol and triglycerides (as statins do), but also blood pressure and blood glucose.